Retatrutide is a notable triple-agonist peptide, which means it targets three different hormone receptors: GLP-1 (glucagon-like peptide-1), GIP (gastric inhibitory polypeptide), and glucagon. These hormones play vital roles in regulating blood sugar, appetite, and energy expenditure, making Retatrutide a promising candidate for treating obesity and potentially type 2 diabetes mellitus.

Retatrutide is an innovative peptide with a complex mechanism of action, making it highly effective for weight loss and diabetes management. It functions primarily through three mechanisms: as a Gastric inhibitory polypeptide receptor (GIPR) agonist, it enhances appetite suppression and prevents fat accumulation by improving the body's response to insulin. As a Glucagon-like peptide 1 receptor (GLP-1R) agonist, retatrutide stimulates insulin release in response to high blood glucose levels, simu

This product requires bacteriostatic water for reconstruction.